| P50 | author | Alisa M Higgins | Q56855476 |
| | Wendy Erber | Q58375695 |
| | Edward Litton | Q87853317 |
| | Australian and New Zealand Intensive Care Society Clinical Trials Group | Q113288324 |
| | John K. Olynyk | Q37830523 |
| P2093 | author name string | Axel Hofmann | |
| | Toby Richards | |
| | Steve Webb | |
| | Craig French | |
| | David Hawkins | |
| | Robert Trengove | |
| | Shannon Farmer | |
| | Bart De Keulenaer | |
| | Simon Towler | |
| | Janet Ferrier | |
| | Joel Gummer | |
| | Stuart Baker | |
| | Julie McMorrow | |
| | IRONMAN Study investigators | |
| P2860 | cites work | Anemia and blood transfusion in critically ill patients. | Q44266321 |
| | A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. | Q46737077 |
| | Intravenous Iron Therapy in Patients Undergoing Cardiovascular Surgery: A Narrative Review | Q47220304 |
| | Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia | Q48178769 |
| | Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness. | Q50226676 |
| | Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. | Q53101230 |
| | Hepcidin in the diagnosis of iron disorders | Q26752500 |
| | Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials | Q26829377 |
| | Anemia in critical illness: insights into etiology, consequences, and management | Q33738712 |
| | Red blood cell transfusion in the critically ill patient | Q35520728 |
| | Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children | Q35955702 |
| | Modeling nonlinear dose-response relationships in epidemiologic studies: statistical approaches and practical challenges | Q36780497 |
| | Hepcidin and anemia of the critically ill patient: bench to bedside | Q37831781 |
| | The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. | Q38417623 |
| | Iron Parameters Determine the Prognosis of Critically Ill Patients | Q39954397 |
| | Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis C. | Q40501827 |
| | Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia | Q43137967 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intensive care unit | Q5094647 |
| P304 | page(s) | 60 | |
| P577 | publication date | 2018-09-10 | |
| P1433 | published in | Journal of intensive care | Q27725973 |
| P1476 | title | Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study | |
| P478 | volume | 6 | |